Highlights Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse Other stock markets 02:30:02 13/01/2026 am IST			After hours 06:30:00 am
209.72 ^USD	+2.61%		211.50	+0.85%

04:53am	Johnson & Johnson's $1 billion loss from robotics takeover reduced by Delaware top court	RE
13/01	Johnson & Johnson Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 08:15 AM

Highlights

04:53am	Johnson & Johnson's $1 billion loss from robotics takeover reduced by Delaware top court	RE
12/01	ServiceNow, Inc. : The Control Layer of the Enterprise AI Stack
10/01	Johnson & Johnson Announces New Longer Follow-Up Results from the Investigational Phase 1b/2 OrigAMI-1 Study Evaluating amivantamab-vmjw	CI
10/01	Health Care Up Amid Deal Speculation -- Health Care Roundup	DJ
09/01	Why weaker jobs won't mean quicker rate cuts
09/01	Johnson & Johnson, US Government Reach Drug Discount, $55 Billion Manufacturing Deal	MT
09/01	EMEA Morning Briefing : Investors Await U.S. Jobs Data	DJ
09/01	Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments	CI
08/01	Lexeo Therapeutics, Johnson & Johnson Collaborate on Heart Disease Gene Therapy	MT
08/01	Lexeo Therapeutics Announces Research Collaboration with Johnson & Johnson to Explore Targeted Cardiac Delivery of Aav Gene Therapy	CI
08/01	Trump administration cannot proceed with pilot drug rebate program, US court rules	RE
08/01	Sector Update: Health Care Stocks Gain Late Afternoon	MT
08/01	Sector Update: Health Care Stocks Advance Wednesday Afternoon	MT
07/01	Bayer Unit Sues Pfizer, BioNTech, Moderna for Technology Misuse in COVID-19 Vaccine Production	MT
07/01	Johnson & Johnson Files De Novo Request With US FDA for Ottava Surgery Robot	MT
07/01	Johnson & Johnson Submits OTTAVA Robotic Surgical System to the U.S. Food and Drug Administration	CI
07/01	Geopolitics Tests the Rally
07/01	Bayer's Monsanto Sues Pfizer, Over COVID Vaccine Makers Over mRNA Technology Patents	MT
07/01	Bayer Unit Sues Pfizer, BioNTech, Moderna for Technology Misuse in COVID-19 Vaccine Production	MT
07/01	Bayer's Monsanto Sues Pfizer, Over COVID Vaccine Makers Over mRNA Technology Patents	MT
07/01	Bayer Sues Biontech and Pfizer Over Patents for Covid Vaccines	RE
07/01	Bayer Unit Sues Pfizer, BioNTech, Moderna for Technology Misuse in COVID-19 Vaccine Production	MT
07/01	Bayer Unit Sues Pfizer, BioNTech, Moderna for Technology Misuse in COVID-19 Vaccine Production	MT
07/01	Bayer sues COVID vaccine makers over mRNA technology	RE
07/01	Johnson & Johnson Unveils New Data Showing Nipocalimab Is the First and Only Investigational Fcrn Backer with Potential to Reduce Systemic Lupus Erythematosus Activity in A Phase 2 Study	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

J&J CFO Wolk on Orthopedics Spinoff, Earnings, Drug Pricing

October 14, 2025 at 09:50 pm IST

Johnson & Johnson: A Dose of Resilience Amid Trade Tensions

April 15, 2025 at 07:23 pm IST